Bank of America’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.9M | Buy |
143,609
+83,598
| +139% | +$8.91M | ﹤0.01% | 2629 |
|
|
2025
Q4 | $6.19M | Buy |
60,011
+9,249
| +18% | +$900K | ﹤0.01% | 3215 |
|
|
2025
Q3 | $4.59M | Sell |
50,762
-8,875
| -15% | -$777K | ﹤0.01% | 4095 |
|
|
2025
Q2 | $5.25M | Sell |
59,637
-118,459
| -67% | -$10.3M | ﹤0.01% | 3849 |
|
|
2025
Q1 | $16.2M | Buy |
178,096
+68,859
| +63% | +$6.2M | ﹤0.01% | 2675 |
|
|
2024
Q4 | $9.42M | Buy |
109,237
+5,447
| +5% | +$493K | ﹤0.01% | 3004 |
|
|
2024
Q3 | $9.86M | Buy |
103,790
+13,978
| +16% | +$1.33M | ﹤0.01% | 3084 |
|
|
2024
Q2 | $8.22M | Sell |
89,812
-318,781
| -78% | -$28.5M | ﹤0.01% | 3146 |
|
|
2024
Q1 | $37.1M | Sell |
408,593
-216,701
| -35% | -$19M | ﹤0.01% | 1716 |
|
|
2023
Q4 | $50.9M | Sell |
625,294
-43,323
| -6% | -$3.4M | 0.01% | 1353 |
|
|
2023
Q3 | $53.4M | Sell |
668,617
-345,811
| -34% | -$27.9M | 0.01% | 1243 |
|
|
2023
Q2 | $79.9M | Buy |
1,014,428
+236,284
| +30% | +$18.5M | 0.01% | 1004 |
|
|
2023
Q1 | $60.4M | Buy |
778,144
+480,478
| +161% | +$37M | 0.01% | 1233 |
|
|
2022
Q4 | $23.1M | Buy |
297,666
+215,344
| +262% | +$15.9M | ﹤0.01% | 1899 |
|
|
2022
Q3 | $5.54M | Sell |
82,322
-10,841
| -12% | -$799K | ﹤0.01% | 3238 |
|
|
2022
Q2 | $7.16M | Buy |
93,163
+64,748
| +228% | +$5.05M | ﹤0.01% | 3013 |
|
|
2022
Q1 | $2.27M | Sell |
28,415
-12,267
| -30% | -$939K | ﹤0.01% | 4464 |
|
|
2021
Q4 | $3.13M | Sell |
40,682
-84,459
| -67% | -$6.28M | ﹤0.01% | 4116 |
|
|
2021
Q3 | $9.11M | Sell |
125,141
-40,207
| -24% | -$3M | ﹤0.01% | 2954 |
|
|
2021
Q2 | $12.1M | Sell |
165,348
-359,726
| -69% | -$25.7M | ﹤0.01% | 2637 |
|
|
2021
Q1 | $36.2M | Buy |
525,074
+495,137
| +1,654% | +$34.1M | ﹤0.01% | 1542 |
|
|
2020
Q4 | $1.99M | Sell |
29,937
-499,884
| -94% | -$32M | ﹤0.01% | 3953 |
|
|
2020
Q3 | $32.9M | Buy |
529,821
+499,478
| +1,646% | +$31.6M | ﹤0.01% | 1339 |
|
|
2020
Q2 | $1.89M | Sell |
30,343
-85,035
| -74% | -$5.14M | ﹤0.01% | 3671 |
|
|
2020
Q1 | $6.28M | Buy |
115,378
+73,212
| +174% | +$4.51M | ﹤0.01% | 2463 |
|
|
2019
Q4 | $2.71M | Sell |
42,166
-801,872
| -95% | -$48.3M | ﹤0.01% | 3780 |
|
|
2019
Q3 | $48.1M | Buy |
844,038
+721,767
| +590% | +$41.3M | 0.01% | 1153 |
|
|
2019
Q2 | $7.17M | Buy |
122,271
+66,917
| +121% | +$3.87M | ﹤0.01% | 2879 |
|
|
2019
Q1 | $3.36M | Sell |
55,354
-18,719
| -25% | -$1.11M | ﹤0.01% | 3544 |
|
|
2018
Q4 | $4.06M | Sell |
74,073
-2,175
| -3% | -$132K | ﹤0.01% | 3219 |
|
|
2018
Q3 | $4.91M | Sell |
76,248
-2,351
| -3% | -$147K | ﹤0.01% | 3196 |
|
|
2018
Q2 | $4.64M | Sell |
78,599
-76,586
| -49% | -$4.44M | ﹤0.01% | 3236 |
|
|
2018
Q1 | $8.82M | Buy |
155,185
+63,660
| +70% | +$3.8M | ﹤0.01% | 2526 |
|
|
2017
Q4 | $5.43M | Sell |
91,525
-1,130,842
| -93% | -$64.8M | ﹤0.01% | 3048 |
|
|
2017
Q3 | $70.6M | Buy |
1,222,367
+1,150,456
| +1,600% | +$65.3M | 0.01% | 929 |
|
|
2017
Q2 | $4.25M | Sell |
71,911
-13,553
| -16% | -$767K | ﹤0.01% | 3193 |
|
|
2017
Q1 | $4.71M | Sell |
85,464
-36,963
| -30% | -$2M | ﹤0.01% | 3087 |
|
|
2016
Q4 | $6.43M | Buy |
122,427
+91,075
| +290% | +$4.87M | ﹤0.01% | 2694 |
|
|
2016
Q3 | $1.8M | Sell |
31,352
-463
| -1% | -$27.8K | ﹤0.01% | 3721 |
|
|
2016
Q2 | $1.86M | Sell |
31,815
-381
| -1% | -$22.2K | ﹤0.01% | 3688 |
|
|
2016
Q1 | $1.85M | Sell |
32,196
-58,615
| -65% | -$3.47M | ﹤0.01% | 3635 |
|
|
2015
Q4 | $5.93M | Buy |
90,811
+43,029
| +90% | +$2.78M | ﹤0.01% | 2773 |
|
|
2015
Q3 | $3.01M | Buy |
47,782
+261
| +0.5% | +$18.3K | ﹤0.01% | 3385 |
|
|
2015
Q2 | $3.36M | Buy |
47,521
+2,706
| +6% | +$195K | ﹤0.01% | 2963 |
|
|
2015
Q1 | $3.15M | Sell |
44,815
-6,119
| -12% | -$415K | ﹤0.01% | 2849 |
|
|
2014
Q4 | $3.27M | Sell |
50,934
-32,823
| -39% | -$2.09M | ﹤0.01% | 2921 |
|
|
2014
Q3 | $5.32M | Buy |
83,757
+3,026
| +4% | +$187K | ﹤0.01% | 2524 |
|
|
2014
Q2 | $5.01M | Sell |
80,731
-6,142
| -7% | -$365K | ﹤0.01% | 2560 |
|
|
2014
Q1 | $5.07M | Buy |
86,873
+8,696
| +11% | +$492K | ﹤0.01% | 2367 |
|
|
2013
Q4 | $4.15M | Buy |
78,177
+33,836
| +76% | +$1.71M | ﹤0.01% | 2632 |
|
|
2013
Q3 | $2.12M | Sell |
44,341
-2,862
| -6% | -$136K | ﹤0.01% | 3216 |
|
|
2013
Q2 | $2.15M | Buy |
+47,203
| New | +$2.18M | ﹤0.01% | 3125 |
|
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
Bank of America's PPH Position: Q1 2026 in Review
Bank of America increased its VanEck Pharmaceutical ETF (PPH) stake by 139% in Q1 2026, buying an estimated $8.91M and bringing the position to 143,609 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2629.
Bank of America first reported a position in PPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $79.9M in Q2 2023. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- Bank of America held 143,609 shares of VanEck Pharmaceutical ETF worth $14.9M as of Q1 2026.
- Bank of America bought 83,598 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $8.91M.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2629 holding.
- Bank of America first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 52 quarters since.
- Bank of America's VanEck Pharmaceutical ETF position peaked at $79.9M in Q2 2023.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.